STEINMAN LAWRENCE

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
STEINMAN LAWRENCE's trades of Pasithea Therapeutics Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-01 2025-11-28
B Purchase
79,301 -10.6%
136.59
US$4,796,794 		79,301 -10.6% 136.59 US$4,796,794
2025-08-14 2025-08-14
US ETHZilla Corp (ETHZ)
PrS Proposed sale
34,949
136.63
US$4,576,917 		34,949 136.63 US$4,576,917
2023-12-19 2023-12-19
US Bioatla Inc (BCAB)
B Purchase
74,308 -2.7%
483.49
US$499,231 		74,308 -2.7% 483.49 US$499,231
2023-06-06 2023-06-02
B Purchase
30,000 +2.3%
0.43
US$12,930 		30,000 +2.3% 0.43 US$12,930
2023-06-02 2023-06-01
US ETHZilla Corp (ETHZ)
B Purchase
18,000 +59.7%
1.23
US$22,068 		18,000 +59.7% 1.23 US$22,068
2021-12-10 2021-12-09
US ETHZilla Corp (ETHZ)
B Purchase
5,000 +0.8%
4.27
US$21,350 		5,000 +0.8% 4.27 US$21,350
2021-11-03 2021-11-02
US Bioatla Inc (BCAB)
PlS Planned sale
450 -2.4%
30.00
US$13,500 		450 -2.4% 30.00 US$13,500
2021-09-17 2021-09-15
US Bioatla Inc (BCAB)
PlS Planned sale
450 -2.3%
36.82
US$16,569 		450 -2.3% 36.82 US$16,569